Status:

TERMINATED

A Pilot Study of Zavesca® in Patients With Pompe Disease and Infusion Associated Reaction

Lead Sponsor:

University of Florida

Collaborating Sponsors:

Amicus Therapeutics

Conditions:

Pompe Disease

Hypersensitivity Reaction

Eligibility:

All Genders

18-65 years

Phase:

PHASE1

Brief Summary

Hypothesis: the effectiveness of treatment of Pompe disease with rhGAA enzyme replacement therapy (ERT) is limited at least in part because patients develop antibodies against the provided rhGAA enzym...

Detailed Description

This Study is designed to assess the effects of Zavesca® as immunomodulatory therapy on anti-rhGAA immune responses in patients with Pompe disease, as well as their health and disease progression. Sub...

Eligibility Criteria

Inclusion

  • Subjects will be patients between the ages of 18 years and 65 years who have been diagnosed with Pompe Disease, confirmed by mutational analysis and/or GAA enzyme activity assay.
  • Receiving rhGAA ERT
  • Willing to travel to the study site for study assessments
  • Willingness of local medical treatment provider to continue treating study participant with addition of Zavesca® to treatment plan.
  • Willingness of study participant to modify dietary intake on day of infusion \*All Subjects will continue enzyme replacement therapy as standard of care, as prescribed by local medical treatment provider during the course of the Study.

Exclusion

  • Subject is unable to meet the study requirements
  • Subject's medical condition contraindicates participation or Study Investigators feel that participation is otherwise not in the Subject's best interest
  • Subject does not receive ERT treatment
  • Participation in other interventional studies at the time of enrollment that may interfere with this study (at the investigator's discretion)
  • Unable to travel to the University of Florida for study visits

Key Trial Info

Start Date :

October 1 2016

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 1 2018

Estimated Enrollment :

2 Patients enrolled

Trial Details

Trial ID

NCT02185651

Start Date

October 1 2016

End Date

July 1 2018

Last Update

December 5 2018

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.